Business Wire

etouches Secures a Global Partnership with UNICEO

Jaa

etouches, a leading global provider of event management software solutions, today announced its global partnership with UNICEO® (United Networks of International Corporate Event Organizers), a non-profit international association bringing together senior decision-makers in charge of corporate events representing major companies and associations internationally. The partnership provides UNICEO’s corporate events decision-making members with further access to etouches’ world-class event-planning solutions and expertise.

Focused on making events and meetings better for participants, planners, and sponsors, etouches will benefit greatly from this increased exposure to UNICEO’s membership of established leaders in the event planning industry. Through the etouches partnership, UNICEO members will gain the ability to interact with an event management solution that provides support for the entire event planning and management lifecycle, from venue sourcing, to attendee engagement, to post-event analysis.

“UNICEO has a unique stature within the MICE industry, with high-profile members who aim to influence their business outcomes through strong event and meetings strategies,” said etouches’ CEO Oni Chukwu. “Our event management solution is uniquely positioned to provide direct and actionable insights for event organizers, and we hope UNICEO’s members will learn as much from us and our solutions as we are sure to learn from them.”

UNICEO’s membership of corporate event leaders represents 31 countries around the world with a primary focus in Europe and increasing relationships in the U.S. and Asia Pacific regions. Premier members include executives and event planning decision-makers from companies such as Airbus, Siemens, Allianz, Christie’s, Coca-Cola, Exxon Mobil, Renault, L’Oréal, and other global brands. The organization provides its members with an interactive platform to exchange ideas and experiences in order to improve the planning, execution, and value of corporate events.

“This partnership with etouches opens a whole new avenue for our members to learn, teach, and grow,” said Debora Piovesan, vice president of UNICEO. “With access to etouches’ award-winning event management technology solutions, we will be able to better understand how events can create the opportunities necessary for all parts of business to flourish in the global economy.”

To learn more about etouches’ event management and venue sourcing solutions, please stop by booth #O150 at ibtm world, taking place 28-30 November in Barcelona, or visit www.etouches.com.

About etouches

etouches is a global leader in cloud based analytics and data driven end-to-end event management and venue sourcing solutions. The award-winning open source platform delivers innovative technology solutions to streamline the event process, providing real-time data and analytics on event performance, customer engagement, and increasing measurable event ROI. Founded in 2008, etouches has assisted over 25,000 event professionals in planning, executing, and measuring their events. With a focus on event sourcing, registration, marketing, logistics, engagement, mobile, and data analytics, the company serves more than 1,300 customers including leading corporations, associations, agencies, and educational institutions globally. Headquartered in the United States, the company also has offices in the UK, Belgium, Australia, Singapore, India, and UAE. etouches is a portfolio company of private equity firm HGGC. Learn more at etouches.com.

About UNICEO

UNICEO (United Networks of International Corporate Event Organizers) is a non-profit association bringing together senior decision-makers for corporate events representing leading companies, associations, and institutions internationally. UNICEO Members are willing to share experiences, best practices, and information to improve their events, broaden their networks and boost their careers. Learn more at uniceo.org.

Contact information

For etouches
Text100
Crystal Monahan, +1-617-399-4921
crystal.monahan@text100.com
or
For UNICEO
Pedro Dalmases
Communication
info@uniceo.org

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Customers of Palau Telecoms to Enjoy ‘Always On’ Connectivity with SES Networks19.2.2018 10:50Tiedote

Customers of Palau’s local internet services provider Palau Telecoms will continue to enjoy enhanced and reliable fibre-like connectivity delivered by SES Networks. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180218005047/en/ Customers of Palau Telecoms to Enjoy ‘Always On’ Connectivity with SES Networks (Photo: Business Wire) SES announced today that in the latest contract signed, Palau Telecoms, which has been enjoying SES’s Networks exceptional networks performance since 2014, will be extending its contract until 2020, and increasing the amount of medium earth orbit (MEO) connectivity by 150%. A long-term customer of SES Networks, Palau Telecoms is utilising their existing MEO service to augment fibre capacity, providing an ‘always on’ service to its customers. This enhanced, robust infrastructure provides a solid foundation for their 4G implementation plans, giving their end users the quality experience they demand reg

New data presented at the American Academy of Dermatology show LEO Pharma’s Kyntheum® (brodalumab) improves psoriasis on the nail19.2.2018 09:00Tiedote

NOT FOR DISTRIBUTION IN THE UNITED STATES OR UNITED KINGDOM: LEO Pharma today announced new data demonstrating long-term improvements in psoriasis on the nail with Kyntheum® (brodalumab) when compared to placebo or ustekinumab.1 Psoriasis on the nail, which is challenging to treat,2 affects approximately half of the estimated 125 million people living with psoriasis worldwide.2,3 The data were presented at the 76th annual American Academy of Dermatology (AAD) meeting in San Diego, California, US. Psoriasis is a common, chronic, immune-mediated, inflammatory disease that primarily involves the skin, but also impacts emotional, psychological and physical health.4 The heavy and far-reaching burden of the disease can be disabling and stigmatising with a substantial negative impact on those affected and their families.4 Due to the visible nature of the condition, psoriasis on the nail can be particularly upsetting for patients.4 In moderate to severe cases, psoriasis on the nail can be pain

OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers18.2.2018 00:00Tiedote

Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im

CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 11:00Tiedote

Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates

Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 21:26Tiedote

Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a

General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 20:05Tiedote

General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme